BrainsWay Reports Second Quarter 2023 Financial Results and Operational Highlights
09 août 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Aug. 09, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for...
BrainsWay Announces Publication of Three New Deep TMS Research Publications
03 août 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Report Second Quarter 2023 Financial Results on August 9, 2023
26 juil. 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, July 26, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Accelerates International Expansion in India
11 juil. 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, July 11, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Announces Significant Expansion in Western and Central U.S.
21 juin 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, June 21, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Announces Appointment of Ido Marom as CFO
23 mai 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, May 23, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay Reports First Quarter 2023 Financial Results and Operational Highlights
17 mai 2023 07h30 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, May 17, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for...
BrainsWay Launches Investigator Initiated Study (IIS) Program
15 mai 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, May 15, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Report First Quarter 2023 Financial Results on May 17, 2023
03 mai 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, May 03, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation...
BrainsWay to Participate in Clinical TMS Society and American Psychiatric Association Meetings
02 mai 2023 08h00 HE
|
BrainsWay
BURLINGTON, Mass. and JERUSALEM, Israel, May 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive...